Literature DB >> 19820121

Heterologous expression studies of Saccharomyces cerevisiae reveal two distinct trypanosomatid CaaX protease activities and identify their potential targets.

David Z Mokry1, Surya P Manandhar, Kristen A Chicola, George M Santangelo, Walter K Schmidt.   

Abstract

The CaaX tetrapeptide motif typically directs three sequential posttranslational modifications, namely, isoprenylation, proteolysis, and carboxyl methylation. In all eukaryotic systems evaluated to date, two CaaX proteases (Rce1 and Ste24/Afc1) have been identified. Although the Trypanosoma brucei genome also encodes two putative CaaX proteases, the lack of detectable T. brucei Ste24 activity in trypanosome cell extracts has suggested that CaaX proteolytic activity within this organism is solely attributed to T. brucei Rce1 (J. R. Gillespie et al., Mol. Biochem. Parasitol. 153:115-124. 2007). In this study, we demonstrate that both T. brucei Rce1 and T. brucei Ste24 are enzymatically active when heterologously expressed in yeast. Using a-factor and GTPase reporters, we demonstrate that T. brucei Rce1 and T. brucei Ste24 possess partially overlapping specificities much like, but not identical to, their fungal and human counterparts. Of interest, a CaaX motif found on a trypanosomal Hsp40 protein was not cleaved by either T. brucei CaaX protease when examined in the context of the yeast a-factor reporter but was cleaved by both in the context of the Hsp40 protein itself when evaluated using an in vitro radiolabeling assay. We further demonstrate that T. brucei Rce1 is sensitive to small molecules previously identified as inhibitors of the yeast and human CaaX proteases and that a subset of these compounds disrupt T. brucei Rce1-dependent localization of our GTPase reporter in yeast. Together, our results suggest the conserved presence of two CaaX proteases in trypanosomatids, identify an Hsp40 protein as a substrate of both T. brucei CaaX proteases, support the potential use of small molecule CaaX protease inhibitors as tools for cell biological studies on the trafficking of CaaX proteins, and provide evidence that protein context influences T. brucei CaaX protease specificity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19820121      PMCID: PMC2794219          DOI: 10.1128/EC.00169-09

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  51 in total

1.  A biochemical genomics approach for identifying genes by the activity of their products.

Authors:  M R Martzen; S M McCraith; S L Spinelli; F M Torres; S Fields; E J Grayhack; E M Phizicky
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

Review 2.  Thematic review series: lipid posttranslational modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I.

Authors:  Kimberly T Lane; Lorena S Beese
Journal:  J Lipid Res       Date:  2006-02-13       Impact factor: 5.922

3.  Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketones.

Authors:  Stephen B Porter; Emily R Hildebrandt; Sarah R Breevoort; David Z Mokry; Timothy M Dore; Walter K Schmidt
Journal:  Biochim Biophys Acta       Date:  2007-03-20

4.  Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruzi.

Authors:  Mónica I Esteva; Katja Kettler; Cristina Maidana; Laura Fichera; Andrés M Ruiz; Esteban J Bontempi; Björn Andersson; Hans-Martin Dahse; Peter Haebel; Regina Ortmann; Gerhard Klebe; Martin Schlitzer
Journal:  J Med Chem       Date:  2005-11-17       Impact factor: 7.446

Review 5.  Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation.

Authors:  Richard T Eastman; Frederick S Buckner; Kohei Yokoyama; Michael H Gelb; Wesley C Van Voorhis
Journal:  J Lipid Res       Date:  2005-12-07       Impact factor: 5.922

Review 6.  Prelamin A farnesylation and progeroid syndromes.

Authors:  Stephen G Young; Margarita Meta; Shao H Yang; Loren G Fong
Journal:  J Biol Chem       Date:  2006-11-07       Impact factor: 5.157

7.  C-terminal proteolysis of prenylated proteins in trypanosomatids and RNA interference of enzymes required for the post-translational processing pathway of farnesylated proteins.

Authors:  John R Gillespie; Kohei Yokoyama; Karen Lu; Richard T Eastman; James G Bollinger; Wesley C Van Voorhis; Michael H Gelb; Frederick S Buckner
Journal:  Mol Biochem Parasitol       Date:  2007-03-01       Impact factor: 1.759

8.  Sequence dependence of protein isoprenylation.

Authors:  S L Moores; M D Schaber; S D Mosser; E Rands; M B O'Hara; V M Garsky; M S Marshall; D L Pompliano; J B Gibbs
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

9.  Small-molecule inhibitors of the Rce1p CaaX protease.

Authors:  Surya P Manandhar; Emily R Hildebrandt; Walter K Schmidt
Journal:  J Biomol Screen       Date:  2007-10

10.  Rab GTPases containing a CAAX motif are processed post-geranylgeranylation by proteolysis and methylation.

Authors:  Ka Fai Leung; Rudi Baron; Bassam R Ali; Anthony I Magee; Miguel C Seabra
Journal:  J Biol Chem       Date:  2006-11-18       Impact factor: 5.157

View more
  9 in total

1.  Photoaffinity labeling of Ras converting enzyme using peptide substrates that incorporate benzoylphenylalanine (Bpa) residues: improved labeling and structural implications.

Authors:  Kelly Kyro; Surya P Manandhar; Daniel Mullen; Walter K Schmidt; Mark D Distefano
Journal:  Bioorg Med Chem       Date:  2011-10-18       Impact factor: 3.641

2.  Ste24p Mediates Proteolysis of Both Isoprenylated and Non-prenylated Oligopeptides.

Authors:  Emily R Hildebrandt; Buenafe T Arachea; Michael C Wiener; Walter K Schmidt
Journal:  J Biol Chem       Date:  2016-04-29       Impact factor: 5.157

Review 3.  Biogenesis of the Saccharomyces cerevisiae pheromone a-factor, from yeast mating to human disease.

Authors:  Susan Michaelis; Jemima Barrowman
Journal:  Microbiol Mol Biol Rev       Date:  2012-09       Impact factor: 11.056

4.  Modulation of the inhibitor properties of dipeptidyl (acyloxy)methyl ketones toward the CaaX proteases.

Authors:  Anne-Marie R Dechert; James P MacNamara; Sarah R Breevoort; Emily R Hildebrandt; Ned W Hembree; Adam C Rea; Duncan E McLain; Stephen B Porter; Walter K Schmidt; Timothy M Dore
Journal:  Bioorg Med Chem       Date:  2010-07-21       Impact factor: 3.641

5.  Chemical inhibition of CaaX protease activity disrupts yeast Ras localization.

Authors:  Surya P Manandhar; Emily R Hildebrandt; William H Jacobsen; George M Santangelo; Walter K Schmidt
Journal:  Yeast       Date:  2010-06       Impact factor: 3.239

6.  8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells.

Authors:  Idrees Mohammed; Shahienaz E Hampton; Louise Ashall; Emily R Hildebrandt; Robert A Kutlik; Surya P Manandhar; Brandon J Floyd; Haley E Smith; Jonathan K Dozier; Mark D Distefano; Walter K Schmidt; Timothy M Dore
Journal:  Bioorg Med Chem       Date:  2015-11-30       Impact factor: 3.641

7.  Topology of the yeast Ras converting enzyme as inferred from cysteine accessibility studies.

Authors:  Emily R Hildebrandt; Dillon M Davis; John Deaton; Ranjith K Krishnankutty; Edward Lilla; Walter K Schmidt
Journal:  Biochemistry       Date:  2013-09-10       Impact factor: 3.162

8.  Functional expression of parasite drug targets and their human orthologs in yeast.

Authors:  Elizabeth Bilsland; Pınar Pir; Alex Gutteridge; Alexander Johns; Ross D King; Stephen G Oliver
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

Review 9.  Rce1: mechanism and inhibition.

Authors:  Shahienaz E Hampton; Timothy M Dore; Walter K Schmidt
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-02-09       Impact factor: 8.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.